lobbying_activities: 1412353
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1412353 | 57b68015-51bb-4fcd-99f3-b96d27e05fd9 | Q2 | DELAHUNT GROUP, LLC | 401066001 | HEALIANCE PHARMACEUTICALS | 2013 | second_quarter | FOR | innovative diabetes treatment | HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS),Treasury, Dept of | 45000 | 0 | 0 | 2013-07-18T11:47:03.033000-04:00 |